The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Corticosteroids in brain cancer patients: benefits and pitfalls
Open accessAbstract
Glucocorticoids have been used for decades in the treatment of brain tumor patients and belong to the most powerful class of agents in reducing tumor-associated edema and minimizing side effects and the risk of encephalopathy in patients undergoing radiation therapy. Unfortunately, corticosteroids are associated with numerous and well-characterized adverse effects, constituting a major challenge in patients requiring long-term application of corticosteroids. Novel antiangiogenic agents, such as bevacizumab (Avastin®), which have been increasingly used in cancer patients, are associated with significant steroid-sparing effects, allowing neuro-oncologists to reduce the overall use of corticosteroids in patients with progressive malignant brain tumors. Recent experimental studies have revealed novel insights into the mechanisms and effects of corticosteroids in cancer patients, including modulation of tumor biology, angiogenesis and steroid-associated neurotoxicity. This article summarizes current concepts of using corticosteroids in brain cancer patients and highlights potential pitfalls in their effects on both tumor and neural progenitor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Friedman, H. S., Prados, M. D., Wen, P. Y., Mikkelsen, T., Schiff, D., Abrey, L. E., Yung, W. K. A., Paleologos, N., Nicholas, M. K., Jensen, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8721 · Cited by 2,466
Response criteria for phase II studies of supratentorial malignant glioma.
Macdonald, D. R., Cascino, T. L., Schold, S. C., & Cairncross, J. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1277 · Cited by 2,409
Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Persidsky, Y., Ramirez, S. H., Haorah, J., & Kanmogne, G. D. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9025-3 · Cited by 922
Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
American College of Rheumatology task force on Osteoporosis guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391104 · Cited by 848
Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the Fungi
Edman, J. C., Kovacs, J. A., Masur, H., Santi, D. V., Elwood, H. J., & Sogin, M. L. (1988) · Nature · doi:10.1038/334519a0 · Cited by 789
Grossman, J. M., Gordon, R., Ranganath, V. K., Deal, C., Caplan, L., Chen, W., Curtis, J. R., Furst, D. E., McMahon, M., Patkar, N. M., et al. (2010) · Arthritis Care & Research · doi:10.1002/acr.20295 · Cited by 708
The human glucocorticoid receptor: molecular basis of biologic function
Nicolaides, N. C., Galata, Z., Kino, T., Chrousos, G. P., & Charmandari, E. (2010) · Steroids · doi:10.1016/j.steroids.2009.09.002 · Cited by 436
Molecular mechanisms of glucocorticoid action and resistance
Schaaf, M. J. M., & Cidlowski, J. A. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00263-7 · Cited by 416
Glucocorticoids in T cell apoptosis and function
Herold, M. J., McPherson, K. G., & Reichardt, H. M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5390-y · Cited by 397
Glucocorticoid use in acute lymphoblastic leukaemia
Inaba, H., & Pui, C.-H. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70114-5 · Cited by 367
Ryken, T. C., McDermott, M., Robinson, P. D., Ammirati, M., Andrews, D. W., Asher, A. L., Burri, S. H., Cobbs, C. S., Gaspar, L. E., Kondziolka, D., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0057-4 · Cited by 363
Nonassociation of Adrenocorticosteroid Therapy and Peptic Ulcer
Conn, H. O., & Blitzer, B. L. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602262940905 · Cited by 353
The role of the glucocorticoid receptor in inflammation and immunity
Baschant, U., & Tuckermann, J. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.058 · Cited by 352
Vecht, C. J., Hovestadt, A., Verbiest, H. B. C., van Vliet, J. J., & van Putten, W. L. J. (1994) · Neurology · doi:10.1212/wnl.44.4.675 · Cited by 352
Pneumocystis carinii Pneumonia Among Patients Without AIDS at a Cancer Hospital
Sepkowitz, K. A. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480060078034 · Cited by 323
Molecular mechanisms of brain tumor edema
Papadopoulos, M. C., Saadoun, S., Binder, D. K., Manley, G. T., Krishna, S., & Verkman, A. S. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.044 · Cited by 308
Steroid myopathy in connective tissue disease
Askari, A., Vignos, P. J., & Moskowitz, R. W. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90327-2 · Cited by 289
Use of dexamethasone in treatment of cerebral edema associated with brain tumors.
Galicich, J. H., French, L. A., & MELBY, J. C. (1961) · PubMed · Cited by 263
Franchimont, D., Galon, J., Gadina, M., Visconti, R., Zhou, Y.-J., Aringer, M., Frucht, D. M., Chrousos, G. P., & O’Shea, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1768 · Cited by 260
Heiss, J. D., Papavassiliou, E., Merrill, M. J., Nieman, L., Knightly, J. J., Walbridge, S., Edwards, N. A., & Oldfield, E. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118927 · Cited by 256
End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria
van den Bent, M. J., Vogelbaum, M. A., Wen, P. Y., Macdonald, D. R., & Chang, S. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.4998 · Cited by 240
Machein, M. R., & Plate, K. H. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006416003964 · Cited by 236
Förster, C., Silwedel, C., Golenhofen, N., Burek, M., Kietz, S., Mankertz, J., & Drenckhahn, D. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.084038 · Cited by 214
VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer
Gerstner, E. R., Duda, D. G., di Tomaso, E., Ryg, P. A., Loeffler, J. S., Sorensen, A. G., Ivy, P., Jain, R. K., & Batchelor, T. T. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.14 · Cited by 208
Medical management of patients with brain tumors
Wen, P. Y., Schiff, D., Kesari, S., Drappatz, J., Gigas, D. C., & Doherty, L. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9193-2 · Cited by 191
Self-citationDrug-induced myopathies. An overview of the possible mechanisms.
Owczarek, J., Jasińska-Stroschein, M., & Orszulak–Michalak, D. (2005) · PubMed · Cited by 187
Cifone, M. G., Migliorati, G., Parroni, R., Marchetti, C., Millimaggi, D., Santoni, A., & Riccardi, C. (1999) · Blood · doi:10.1182/blood.v93.7.2282 · Cited by 187
Antiemetic Efficacy of Dexamethasone
Markman, M. M., Sheidler, V. R., Ettinger, D. S., Quaskey, S. A., & Mellits, E. D. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408303110901 · Cited by 175
Cognitive decline in patients with Cushing's syndrome
FORGET, H., LACROIX, A., SOMMA, M., & COHEN, H. (2000) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700611037 · Cited by 161
Corticosteroids: a review with emphasis on complications of prolonged systemic therapy.
Truhan, A. P., & Ahmed, A. R. (1989) · PubMed · Cited by 155
Molecular Mechanisms and Cellular Effects of Glucocorticosteroids
Barnes, P. J. (2005) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2005.05.003 · Cited by 153
Regulation of Leukocyte‐Endothelial Interactions by Glucocorticoids
Pitzalis, C., Pipitone, N., & Perretti, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04208.x · Cited by 152
TREATMENT OF CEREBRAL METASTASES FROM BREAST CARCINOMA WITH PREDNISOLONE
Kofman, S. (1957) · JAMA · doi:10.1001/jama.1957.02970510039008 · Cited by 150
BRAIN WATER MEASURED BY MAGNETIC RESONANCE IMAGING
Bell, B. A., Kean, D. M., MacDonald, H. L., et al. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91908-8 · Cited by 149
Dexamethasone inhibits proliferation of adult hippocampal neurogenesis in vivo and in vitro
Kim, J. B., Ju, J. Y., Kim, J. H., Kim, T., Yang, B., Lee, Y., & Son, H. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.093 · Cited by 147
Studies on Dexamethasone Metabolism in Man: Effect of Diphenylhydantoin
Haque, N. U., Thrasher, K., Werk, E. E., Knowles, H. C., & Sholiton, L. J. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-1-44 · Cited by 139
Sundberg, M., Savola, S. P., Hienola, A., Korhonen, L., & Lindholm, D. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4906-05.2006 · Cited by 131
Quintrec, J. S. L., & Quintrec, J.-S. G.-L. (1991) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(05)80294-8 · Cited by 130
Steroids in neurooncology: actions, indications, side-effects
Roth, P., Wick, W., & Weller, M. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32833e5a5d · Cited by 123
Cortisone and ACTH as an Adjunct to the Surgery of Craniopharyngiomas
Ingraham, F. D., Matson, D. D., & McLaurin, R. L. (1952) · New England Journal of Medicine · doi:10.1056/nejm195204102461502 · Cited by 115
Differential effects of corticosterone and dexamethasone on hippocampal neurogenesis in vitro
Yu, I. T., Lee, S., Lee, Y.-S., & Son, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.071 · Cited by 107
Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas
Lamszus, K., Laterra, J., Westphal, M., & Rosen, E. M. (1999) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(99)00008-8 · Cited by 105
Das, A., Banik, N. L., Patel, S. J., & Ray, S. K. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-36 · Cited by 105
Pneumocystis carinii Pneumonia in Patients With Primary Brain Tumors
Henson, J. W., Jalaj, J. K., Walker, R. W., Stover, D. E., & Fels, A. O. S. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530160074017 · Cited by 103
Effect of dexamethasone on blood‐brain barrier in the normal mouse
Hedley‐Whyte, E. T., & Hsu, D. W. (1986) · Annals of Neurology · doi:10.1002/ana.410190411 · Cited by 100
The eicosanoid cascade: possible role in gliomas and meningiomas: Figure 1
Nathoo, N., Barnett, G. H., & Golubic, M. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.57.1.6 · Cited by 99
A morphological/biochemical study on the actions of corticosteroids on rat skeletal muscle
Kelly, F. J., McGrath, J. A., Goldspink, D. F., & Cullen, M. J. (1986) · Muscle & Nerve · doi:10.1002/mus.880090102 · Cited by 91
Graham, P., Capp, A., Delaney, G. P., Goozée, G., Hickey, B. E., Turner, S., Browne, L. H., Milross, C. G., & Wirth, A. (2005) · Clinical Oncology · doi:10.1016/j.clon.2005.08.015 · Cited by 70
Blecharz, K., Drenckhahn, D., & Förster, C. Y. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.2 · Cited by 63
EFFECT OF DIPHENYLHYDANTOIN ON CORTISOL KINETICS IN HUMANS
Choi, Y. J., Thrasher, K., Werk, E. E., Sholiton, L. J., & Olinger, C. P. (1971) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28757-2 · Cited by 63
Ph, G. (1975) · PubMed · Cited by 62
Portnow, J., Suleman, S., Grossman, S. A., Eller, S., & Carson, K. (2002) · Neuro-Oncology · doi:10.1093/neuonc/4.1.22 · Cited by 53
Adrenocorticosteroid administration and peptic ulcer: A critical analysis
Conn, H. O., & Poynard, T. (1985) · Journal of Chronic Diseases · doi:10.1016/0021-9681(85)90028-1 · Cited by 52
Molecular Mechanisms of Glucocorticoids
Cosío, B. G., Torregó, A., & Adcock, I. M. (2005) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(06)60392-3 · Cited by 52
Medical Management of Cerebral Metastases
Batchelor, T. T., & DeAngelis, L. M. (1996) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(18)30371-1 · Cited by 50
The low risk of upper gastrointestinal bleeding in patients dispensed corticosteroids
Carson, J. L., Strom, B. L., Schinnar, R., Duff, A., & Sim, E. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90119-i · Cited by 48
Portnow, J. (2002) · Neuro-Oncology · doi:10.1215/15228517-4-1-22 · Cited by 36
New therapeutic agents for the treatment of bone diseases
Lipton, A. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.6.817 · Cited by 34
Dexamethasone blocks astroglial differentiation from neural precursor cells
Sabolek, M., Herborg, A., Schwarz, J., & Storch, A. (2006) · Neuroreport · doi:10.1097/01.wnr.0000236862.08834.50 · Cited by 30
Kimura, K., Kanda, F., Okuda, S., & Chihara, K. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01667-6 · Cited by 15
Cited by
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Okada, H., Weller, M., Huang, R., Finocchiaro, G., Gilbert, M. R., Wick, W., Ellingson, B. M., Hashimoto, N., Pollack, I. F., Brandes, A. A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00088-1 · Cited by 781
Edlmann, E., Giorgi-Coll, S., Whitfield, P. C., Carpenter, K. L. H., & Hutchinson, P. J. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0881-y · Cited by 729
Brown, C. E., Aguilar, B., Starr, R., Yang, X., Chang, W.-C., Weng, L., Chang, B., Sarkissian, A., Brito, A., Sanchez, J. F., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.10.002 · Cited by 299
NLRC5/MHC class I transactivator is a target for immune evasion in cancer
Yoshihama, S., Roszik, J., Downs, I., Meissner, T. B., Vijayan, S., Chapuy, B., Sidiq, T., Shipp, M. A., Lizee, G. A., & Kobayashi, K. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602069113 · Cited by 276
Siderophores: More than Stealing Iron
Behnsen, J., & Raffatellu, M. (2016) · mBio · doi:10.1128/mbio.01906-16 · Cited by 79
Metadata
- Authors
- Dietrich, J., Rao, K., Pastorino, S., & Kesari, S.
- Venue
- Expert Review of Clinical Pharmacology
- Publisher
- Informa UK Limited
- Published
- 2011-03
- Volume
- 4
- Issue
- 2
- Pages
- 233-242
- ISSN
- 1751-2433 (ISSN-L)
- 1751-2441
- OpenAlex
- W2141713308
- Cited by
- 361
- References
- 60
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.